Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases

Publisher： Karger

E-ISSN： 1421-9875|35|3|288-292

ISSN： 0257-2753

Source： Digestive Diseases, Vol.35, Iss.3, 2017-03, pp. : 288-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 433-439

Karger

Access to resources Recommend Favorite

Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 282-287

Karger

Access to resources Recommend Favorite

Novel Aspects in the Management of Cholestatic Liver Diseases

By  

Digestive Diseases, Vol. 34, Iss. 4, 2016-05 ,pp. : 340-346

Karger

Access to resources Recommend Favorite

An Update on Genetic Analysis of Cholestatic Liver Diseases: Digging Deeper

By  

Digestive Diseases, Vol. 29, Iss. 1, 2011-06 ,pp. : 72-77

Karger

Access to resources Recommend Favorite

Effect of Ursodeoxycholic Acid on Granulomatous Liver Disease Due to Sarcoidosis

By Alenezi Bader   Lamoureux Esther   Alpert Lesley   Szilagyi Andrew  

Digestive Diseases and Sciences, Vol. 50, Iss. 1, 2005-01 ,pp. : 196-200

Springer Publishing Company

Access to resources Recommend Favorite